Recent HAE News
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 • PR Newswire (US) • 04/10/2024 08:58:00 PM
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge • PR Newswire (US) • 04/04/2024 10:30:00 AM
- Haemonetics Corporation Completes Acquisition of Attune Medical • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:10:30 AM
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical • PR Newswire (US) • 03/05/2024 11:00:00 AM
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference • PR Newswire (US) • 02/21/2024 10:57:00 PM
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day • PR Newswire (US) • 02/21/2024 10:55:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 08:28:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:49:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:21:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 11:06:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:05:21 AM
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website • PR Newswire (US) • 02/08/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:13:59 PM
- Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 • PR Newswire (US) • 01/11/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 11:09:57 AM
- Haemonetics Corporation Completes Acquisition of OpSens Inc. • PR Newswire (US) • 12/12/2023 11:00:00 AM
- Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/07/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:36:29 PM
- OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS • PR Newswire (Canada) • 11/02/2023 11:00:00 AM
- OPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE CIRCULAIRE DE SOLLICITATION DE PROCURATIONS RELATIVEMENT À L'ASSEMBLÉE EXTRAORDINAIRE DES ACTIONNAIRES • PR Newswire (Canada) • 11/02/2023 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 10:19:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 10:16:26 AM
- Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website • PR Newswire (US) • 11/02/2023 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2023 08:27:01 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM